We recently reported that pioglitazone, a triglyceride‐lowering, insulin‐sensitizing PPARG agonist, has differing effects on DPN and DN phenotypes in a mouse model of diabetes 20. The gene discussed is PPARG; the disease is diabetes mellitus.